Pfizer's plan to as much as quadruple U.S. prices for its COVID-19 vaccine next year is beyond Wall Street's expectations and will spur its revenue for years despite weaker than anticipated demand for the new booster shot so far, analysts said.
No, I just think they shouldn’t do the kind of patent hogging that we observe now and make instructions to produce the vaccine freely available. Like that we can have healthy competition on who is able to produce the vaccine most efficiently. I am pretty sure this would drive pricing down a lot.
No, I just think they shouldn’t do the kind of patent hogging that we observe now and make instructions to produce the vaccine freely available. Like that we can have healthy competition on who is able to produce the vaccine most efficiently. I am pretty sure this would drive pricing down a lot.
It would, but it would also slow their investment into new treatments, if everybody can just copy it.